USPSTF No Longer Recommends Aspirin Prophylaxis for Colorectal Cancer, CVD
The new guidelines say there is insufficient evidence to support using aspirin to reduce colorectal cancer incidence or mortality.
The new guidelines say there is insufficient evidence to support using aspirin to reduce colorectal cancer incidence or mortality.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of the Sister Mary Joseph nodule.
A new cancer diagnosis is independently associated with a higher risk of cardiovascular death, stroke, heart failure, and pulmonary embolism.
The highest rate of non-concordant care was seen in patients with cervical cancer.
An interviews conducted with patients and caregivers demonstrated the effects of an early palliative care pathway for advanced colorectal cancer.
New research suggests aspirin may lower the risk for gastric adenocarcinoma in women but not in men.
In addition to improved overall survival, patients in the neoadjuvant arm had longer disease-free survival and locoregional failure-free intervals.
Researchers found a dose-response relationship between antihistamine use and the risk of hepatocellular carcinoma in patients with viral hepatitis.
The median survival was significantly longer in patients who received opioid prescriptions than in those who did not.
Patients with pancreatic ductal adenocarcinoma may have been spared the COVID-related delays in care seen for other cancers, according to researchers.